Technical Analysis for GRPH - Graphite Bio, Inc.

Grade Last Price % Change Price Change
D 20.84 0.58% 0.12
GRPH closed up 0.58 percent on Wednesday, August 4, 2021, on 43 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical GRPH trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Hot IPO Pullback Bullish Swing Setup 0.58%
Narrow Range Bar Range Contraction 0.58%
NR7 Range Contraction 0.58%
Inside Day Range Contraction 0.58%
Older End-of-Day Signals for GRPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% about 21 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
Outside Day about 22 hours ago
Fell Below Previous Day's Low about 22 hours ago
Hot IPO Pullback Entry about 23 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Graphite Bio, Inc. Description

Graphite Bio is a clinical-stage, next-generation gene editing company harnessing high efficiency targeted gene integration to develop a new class of therapies to potentially cure a wide range of serious and life-threatening diseases. Graphite Bio is pioneering a precision gene editing approach that could enable a variety of applications to transform human health through its potential to achieve one of medicine’s most elusive goals: to precisely "find & replace" any gene in the genome. Graphite Bio’s platform allows it to precisely correct mutations, replace entire disease-causing genes with normal genes or insert new genes into predetermined, safe locations. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, including Maria Grazia Roncarolo, M.D., and Matthew Porteus, M.D., Ph.D.


Classification

Sector: Other
Industry: Other
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Gene Therapy Genetic Engineering Bioethics

Is GRPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 34.0
52 Week Low 18.45
Average Volume 474,352
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 23.72
10-Day Moving Average 22.03
Average True Range 2.49
ADX 20.59
+DI 16.32
-DI 16.66
Chandelier Exit (Long, 3 ATRs) 21.52
Chandelier Exit (Short, 3 ATRs) 27.23
Upper Bollinger Bands 27.86
Lower Bollinger Band 19.58
Percent B (%b) 0.15
BandWidth 34.92
MACD Line -1.66
MACD Signal Line -1.20
MACD Histogram -0.4552
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.29
Resistance 3 (R3) 22.33 21.89 22.05
Resistance 2 (R2) 21.89 21.52 21.87 21.97
Resistance 1 (R1) 21.36 21.29 21.62 21.32 21.89
Pivot Point 20.92 20.92 21.05 20.90 20.92
Support 1 (S1) 20.40 20.55 20.66 20.36 19.79
Support 2 (S2) 19.95 20.32 19.93 19.71
Support 3 (S3) 19.43 19.95 19.63
Support 4 (S4) 19.39